Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
4R44GM069291-02
Application #
6814214
Study Section
Special Emphasis Panel (ZRG1-SSS-Y (92))
Program Officer
Wolfe, Paul B
Project Start
2003-08-01
Project End
2004-08-31
Budget Start
2004-02-01
Budget End
2004-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$332,580
Indirect Cost

  Institution

Name
Oscient Pharmaceuticals Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453

  Publications

Anisowicz, Anthony; Huang, Hui; Braunschweiger, Karen I et al. (2008) A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer 8:222
Del Mastro, Richard G; Turenne, Laura; Giese, Heidi et al. (2007) Mechanistic role of a disease-associated genetic variant within the ADAM33 asthma susceptibility gene. BMC Med Genet 8:46